Close Search
JDDonline - Journal of Drugs in Dermatology
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In
  • x-twitter facebook linkedin instagram
Aug 03
Love0

Evaluation of a Neck Cream Developed to Enhance Nitric Oxide Availability in Aging Skin

By Chuck Lin No Comments
INTRODUCTIONIt is well known that regions of human skin exposed to the environment can incur significant damage due to sun, wind, and indoor and outdoor pollutants. The pathological effects of…
Read More
Aug 01
Love0

Dermatology in Contemporary Times: Building Awareness of Social Media’s Association With Adolescent Skin Disease and Mental Health

By Chuck Lin No Comments
INTRODUCTION Adolescence is a period during which individuals are subject to a high psychological burden and are often inclined toward depression and anxiety.1,2 During this vulnerable time, the visibility of…
Read More
Aug 01
Love0

FULL SUPPLEMENT: Fixed Combination Calcipotriene/Betamethasone (Cal/BDP) Cream: Evaluating the Role of Polyaphron Dispersion (PAD) Technology in Psoriasis Treatment

By Chuck Lin No Comments
Read More
Aug 01
Love0

FULL SUPPLEMENT: Management of Atopic Dermatitis in People with Skin of Color: A Practical Algorithm

By Chuck Lin No Comments
Read More
Jul 31
Love0

EXTRA, EXTRA, Treatment Approaches for EXTRAmammary Paget Disease

By Chuck Lin No Comments
INTRODUCTIONExtramammary Paget Disease (EMPD) is a rare intraepithelial malignancy of pluripotent keratinocyte stem cells that presents on apocrine-rich skin of the perineum, vulva, and less commonly, axilla.1 EMPD clinically presents…
Read More
Jul 31
Love0

No Racial Differences Found in Access to Biologics: A Population-Based Study of Psoriasis Patients in the United States

By Chuck Lin No Comments
INTRODUCTIONPsoriasis is a chronic inflammatory disease that affects more than 7.5 million people in the United States.1 Although psoriasis is most prevalent in whites (3.2%), African Americans often exhibit more…
Read More
Jul 31
Love0

Rethinking the Inflammatory Balance in Psoriasis and Atherosclerosis

By Chuck Lin No Comments
INTRODUCTIONPsoriasis and atherosclerosis have largely been understood as inflammatory diseases. While these two diseases have complex pathophysiologies, they both appear to be mixed Th1/Th17 cell-driven and tied together through the…
Read More
Jul 31
Love0

Long-Term Safety and Efficacy of Twice-Daily Topical Clascoterone Cream 1% in Patients Greater Than or Equal to 12 Years of Age With Acne Vulgaris

By Chuck Lin No Comments
INTRODUCTIONAcne vulgaris is a chronic skin condition characterized by excess sebum production, hyperkeratinization, Cutibacterium acnes colonization, and inflammation.1 Acne vulgaris affects approximately 85% of adolescents and young adults between 12…
Read More
Jul 31
Love0

Antimalarials are not Effective as Pre-Exposure Prophylaxis for COVID-19: A Retrospective Matched Control Study

By Chuck Lin No Comments
To the editor: The early phase of the COVID-19 pandemic prompted a repurposing of antiviral and immunomodulatory drugs as investigational therapeutics, including hydroxychloroquine and chloroquine.1 Despite an early interest in…
Read More
Jul 31
Love0

Off-Label Use of Baricitinib in Dermatology

By Chuck Lin No Comments
INTRODUCTIONBaricitinib is a reversible Janus kinase (JAK) 1 and 2 inhibitor approved for use in the European Union and the United States for various dermatological conditions. In the US, current…
Read More
Jul 31
Love0

Psoriasis and Skin Barrier Dysfunction: The Role of Gentle Cleansers and Moisturizers in Treating Psoriasis

By Chuck Lin No Comments
INTRODUCTIONPsoriasis is a chronic, immune-mediated, multisystemic skin disease with an estimated prevalence rate of over 2% of the United States population.1 Adults are more frequently affected by psoriasis than children,…
Read More
Jul 31
Love0

Tildrakizumab in Combination With Topical Halcinonide 0.1% Ointment for Treating Moderate to Severe Plaque Psoriasis

By Chuck Lin No Comments
INTRODUCTIONPsoriasis is a chronic inflammatory skin disease prevalent in approximately 3% of adults in the United States.1 It is characterized by marked inflammation and increased epidermal thickness resulting from infiltration…
Read More
« Previous
NextPrevious »

Search page

Advertisement

Popular

  • A Review of the Role of C. Acnes and its Biofilm in Dandruff Pathogenesis May 22, 2025
  • Weight Change and Dose Adjustment in Isotretinoin Therapy: A Retrospective Study May 21, 2025
  • JDD in the News: Upadacitinib’s Potential Cardiovascular Effects  May 21, 2025
  • Need for Speed: Topical Roflumilast for Rapid Control of Seborrheic Dermatitis Flares May 20, 2025
  • Dermatology Roundup: Survey Shows Misconceptions About Sunscreen and Skin Aging May 20, 2025

Advertisement

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
CONTACT US     |      FEEDBACK    |      TERMS     |      COOKIE POLICY    |     PRIVACY    |      EDITORIAL POLICY    |      ADVERTISING POLICY

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
DermAtlas        Derm In-Review         PDE        Next Steps in Derm         Skin of Color Update     ODAC Dermatology, Aesthetic & Surgical Conference

Journal of Drugs in Dermatology

  • About Us
  • Contact Us
  • Contact Sales
  • Editorial Board
  • eJDD
  • Institutional, Library, & Corporate Subscriptions
  • Log In
  • Open Access
  • Permissions Request
  • Podcast Sponsorship
  • Subscription Info
  • Store

© 2025 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

  • twitter
  • facebook
  • linkedin
  • instagram
Close Menu
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In

Search